2,6-Dimethoxy-5(3)-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 1g

Anti-GM2 Monoclonal Antibody1vial

Benzoimidazol-1-yl-acetic acid, 95.0%, 10g

3-Phenyl-1-(tetrahydro-2H-pyran-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 100mg

(2-Iodoethyl)benzene (stabilized with Copper chip), 97.0%, 100g

4-Bromo-5-phenyl-3-trifluoromethylpyrazole, 97.0%, 5g

4-methyl-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione, 95.0%, 1g

4-CYCLOPROPYL-2-FLUORO-6-METHYLBENZAMIDE, 95.0%, 250mg

H-beta-Ala-Obzl Tos, 95.0%, 500g

4-(5-FLUORO-1H-INDOL-3-YL)-3,6-DIHYDRO-2H-PYRIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER, 97.0%, 250mg

2-Chloro-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 95%, 250mg

5-Bromo-6-chloropicolinaldehyde, 95.0%, 100mg

Ethyl-(5-phenyl-[1,3,4]oxadiazol-2-ylmethyl)-amine, 98%, 1g